These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Redefining the Spectrum of Pentosan Polysulfate Retinopathy: Multimodal Imaging Findings from a Cross-Sectional Screening Study. Dieu AC; Whittier SA; Domalpally A; Pak JW; Voland RP; Boyd KM; Gottlieb JL; Crabtree GS; Giles DL; McAchran SE; Mititelu M Ophthalmol Retina; 2022 Sep; 6(9):835-846. PubMed ID: 35339727 [TBL] [Abstract][Full Text] [Related]
4. Identification of Patients with Pentosan Polysulfate Sodium-Associated Maculopathy through Screening of the Electronic Medical Record at an Academic Center. Higgins K; Welch RJ; Bacorn C; Yiu G; Rothschild J; Park SS; Moshiri A J Ophthalmol; 2020; 2020():8866961. PubMed ID: 33489347 [TBL] [Abstract][Full Text] [Related]
6. Type 3 macular neovascularization in a patient with pentosan polysulfate maculopathy. Bousquet E; Lee BA; Santina A; Sadda S; Sarraf D Am J Ophthalmol Case Rep; 2023 Mar; 29():101771. PubMed ID: 36561881 [TBL] [Abstract][Full Text] [Related]
7. Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis. Wang D; Au A; Gunnemann F; Hilely A; Scharf J; Tran K; Sun M; Kim JH; Sarraf D Can J Ophthalmol; 2020 Apr; 55(2):116-125. PubMed ID: 31973791 [TBL] [Abstract][Full Text] [Related]
8. Pigmentary Maculopathy Associated with Chronic Exposure to Pentosan Polysulfate Sodium. Pearce WA; Chen R; Jain N Ophthalmology; 2018 Nov; 125(11):1793-1802. PubMed ID: 29801663 [TBL] [Abstract][Full Text] [Related]
9. Case Report: Pentosan Polysulfate Sodium Maculopathy Originally Diagnosed as Pattern Macular Dystrophy. Case AW; Anderson MJ; Sayomac LE Optom Vis Sci; 2021 Jun; 98(6):552-556. PubMed ID: 34039907 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic Spectrum of Pentosan Polysulfate Sodium-Associated Maculopathy: A Multicenter Study. Hanif AM; Armenti ST; Taylor SC; Shah RA; Igelman AD; Jayasundera KT; Pennesi ME; Khurana RN; Foote JE; O'Keefe GA; Yang P; Hubbard GB; Hwang TS; Flaxel CJ; Stein JD; Yan J; Jain N JAMA Ophthalmol; 2019 Nov; 137(11):1275-1282. PubMed ID: 31486843 [TBL] [Abstract][Full Text] [Related]
12. Pentosan Polysulfate Sodium-Associated Maculopathy: Early Detection Using OCT Angiography and Choriocapillaris Flow Deficit Analysis. Fogel Levin M; Santina A; Corradetti G; Au A; Lu A; Abraham N; Somisetty S; Romero Morales V; Wong A; Sadda S; Sarraf D Am J Ophthalmol; 2022 Dec; 244():38-47. PubMed ID: 35901995 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and Dose Dependency Analysis of Pentosan Polysulfate Sodium Maculopathy. Philip AM; Wannamaker KW; Miller DM Ophthalmic Epidemiol; 2023 Feb; 30(1):82-87. PubMed ID: 35081852 [TBL] [Abstract][Full Text] [Related]
14. Disease Course in Patients With Pentosan Polysulfate Sodium-Associated Maculopathy After Drug Cessation. Shah R; Simonett JM; Lyons RJ; Rao RC; Pennesi ME; Jain N JAMA Ophthalmol; 2020 Aug; 138(8):894-900. PubMed ID: 32644147 [TBL] [Abstract][Full Text] [Related]
15. Nationwide Usage of Pentosan Polysulfate and Practice Patterns of Pentosan Polysulfate Maculopathy Screening in South Korea. Kim J; Kwon HY; Kim JH; Ahn SJ Ophthalmol Retina; 2024 Mar; 8(3):246-253. PubMed ID: 37832716 [TBL] [Abstract][Full Text] [Related]
16. Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation? Proctor JG Can J Urol; 2023 Dec; 30(6):11732-11739. PubMed ID: 38104330 [TBL] [Abstract][Full Text] [Related]
17. Pentosan Polysulfate Maculopathy: Prevalence, Spectrum of Disease, and Choroidal Imaging Analysis Based on Prospective Screening. Wang D; Velaga SB; Grondin C; Au A; Nittala M; Chhablani J; Vupparaboina KK; Gunnemann F; Jung J; Kim JH; Ip M; Sadda S; Sarraf D Am J Ophthalmol; 2021 Jul; 227():125-138. PubMed ID: 33651989 [TBL] [Abstract][Full Text] [Related]